BIVV Insider Trading Activity and SEC Form 4 Filings
BIVV insider trading summary
No open-market insider purchases or sales of Bioverativ Inc. (BIVV) have been reported on SEC Form 4 in the past 12 months.
Latest BIVV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 9, 2017 | Brian S Posner | Director | Buy | $59K (1,000 @ $59.19) |
| Aug 7, 2017 | Louis J Paglia | Director | Buy | $119K (2,000 @ $59.70) |
| Jun 28, 2017 | Diantha Duvall | Chief Accounting Officer | Sell | $49K (818 @ $60.47) |
| May 30, 2017 | Alexander J Denner | Director | Buy | $5.0M (90,000 @ $55.93) |
| May 26, 2017 | Alexander J Denner | Director | Buy | $25.7M (450,000 @ $57.21) |
| May 26, 2017 | Louis J Paglia | Director | Buy | $116K (2,000 @ $57.76) |
| May 25, 2017 | Alexander J Denner | Director | Buy | $7.1M (130,000 @ $54.98) |
| May 24, 2017 | Brian S Posner | Director | Buy | $70K (1,300 @ $53.90) |
| May 24, 2017 | Alexander J Denner | Director | Buy | $18.4M (340,000 @ $54.16) |
| May 24, 2017 | Brian S Posner | Director | Buy | $38K (700 @ $53.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.